Background: The purpose of this study was to determine whether a commercially available pedometer could detect changes in home-based walking activity among chronic obstructive pulmonary disease (COPD) patients completing pulmonary rehabilitation (PR). Methods: Patients with COPD referred to outpatient PR wore a pedometer to count steps for 1 week at the beginning and 1 week at the end of PR. Patients also completed the 6-min walk test (6MWT), the Medical Research Council (MRC) dyspnea scale and the self-administered chronic respiratory disease questionnaire (CRQ) at the beginning and the end of PR. Paired t tests were used to compare pre-and post-PR changes in outcome variables. Results: 45 patients with severe COPD (forced expiratory volume in 1 second [FEV 1 ] 45% + 18% of predicted) participated in a total of 17.4 + 4.6 PR sessions. Significant improvements in 6MWT (49 + 59 m; p < .0001), MRC dyspnea score (À0.64 + 0.96 units; p ¼ .003) and CRQ score (10 + 18 units; p ¼ .0007) were noted following PR. Patients whose pedometermeasured steps were within 20% of observed counted steps were included in the analysis. Pedometer counts increased by 33 + 149 steps per hour worn after, as compared with before PR (p ¼ .14). There was a significant inverse relationship between baseline pedometer counts and change in pedometer counts per hour post-PR (r ¼ À.46; p ¼ .001). Patients with low baseline activity levels had significant increases in pedometer activity (88 + 30 counts per hour worn) and a greater reduction in MRC dyspnea score (À0.94 vs À0.29; p ¼ .04) following PR, whereas those with higher baseline activity levels had a decrease in pedometer activity (À19 + 29 counts/hour; p ¼ .015). Conclusions: A standard pedometer worn at the waist did not detect changes in lower extremity activity following PR. This negative finding occurred despite demonstrated improvements in dyspnea, exercise tolerance and quality of life measures. Although pedometers are inexpensive and easy to use, they may not be sensitive enough to be used routinely as an outcome measure for PR.
Introduction
A key goal of pulmonary rehabilitation (PR) is to optimize functional status in individuals with chronic lung disease. 1 Surrogate indicators of functional status such as the 6-min walk test (6MWT) are traditionally used to assess exercise tolerance before and after PR. Although the 6MWT is responsive to the PR intervention, it is not clear whether an increase in activity in the home setting routinely accompanies this improvement in laboratory-based walking. The indirect measurement of functional status is possible using questionnaires, 2 and existing data suggest that this improves with PR. 3 However, patient recall in questionnaires often overestimates activity. 4, 5 Direct assessment of activity using very-sensitive accelerometers holds promise, [6] [7] [8] and motion detectors worn at the waist and/or ankle have proven able to demonstrate gains in activity following PR. [9] [10] [11] However, these devices are relatively expensive, and clinically meaningful changes following PR have not yet been defined. Pedometers, which are inexpensive, easy to use and familiar to most individuals, can measure walking activity (steps) in healthy persons, [12] [13] [14] in older adults and persons with chronic diseases 15 and in selected patients with chronic obstructive pulmonary disorder (COPD). 16, 17 One study showed that pedometers were useful as a motivational feedback tool for patients who were undergoing PR. 18 However, the ability of pedometers to detect changes in home-based activity of patients with COPD following PR, and to serve as a useful routine outcome assessment tool following PR is still uncertain. Accordingly, we evaluated whether a commercially available pedometer might detect changes in home-based walking activity in COPD patients completing PR, and thus prove useful as an outcome assessment tool.
Methods
Patients with COPD who were referred for rehabilitation at participating centers in the Northeast Pulmonary Rehabilitation Consortium were studied. The consortium is composed of PR programs in Connecticut, New York, and Rhode Island who collaborate on clinical outcomes studies. Although the format of the individual programs varied, each program provided outpatient PR following published guidelines 19 and used standardized outcomes measures for patient assessment. Previous collaborative studies conducted by the consortium have been successful. 20, 21 The local institutional review board's approval to conduct the study was obtained at each of the 10 centers, and informed consent was obtained from each patient before participation. PR was conducted according to routine procedures at each center. Rehabilitation sessions were given two or three times weekly following initial patient assessment. The duration of each program ranged from 6 to 12 weeks with each session including education, psychosocial support and multimodality aerobic and strength exercise training of the lower and upper extremities. Promotion of exercise and increased activity at home through verbal encouragement is standard for each program.
Patient population
Selection criteria included: (1) referral to PR; (2) a clinical diagnosis of COPD; (3) spirometric evidence of airflow limitation (a forced expiratory volume in 1 secondÀforced vital capacity ratio (FEV 1 /FVC) < 0.70); (4) the ability to perform the 6MWT; (5) the absence of comorbid conditions that would put the patient at risk for performing PR or walk testing, or might preclude completion of PR. (6) Patients using ambulatory oxygen were allowed to participate in the study if the above criteria were met. An additional inclusion criterion was the requirement that pedometer-registered steps and visually counted steps were within + 20% of one another during the initial assessment period (see below).
Measurement of patient walking activity
A pedometer that uses a piezoelectric strain gauge to count steps (NL-2000 Activity Monitor, New Lifestyles, Inc.; www.new-lifestyles.com) was studied. This device has shown good accuracy (+ 3%) and reliability in walking tests on an outdoor track among healthy subjects ranging in age from 22 to 69 years. 22 In the pre-rehabilitation assessment, the pedometer was tested for accuracy in detecting steps by having the patient walk at his/her own pace in an indoor corridor while steps were counted visually by an investigator. Generally, patients were instructed to take 100-200 steps, but fewer were taken by some severely debilitated patients. The number of counted steps and the pedometer counts were compared to assure a reliable recording of the number of steps. Only those patients whose pedometer-measured steps were within 20% of the observer counted steps were eligible for the study. A preliminary analysis did not reveal an increase in recorded pedometer activity during periods of driving.
Pre-and post-rehabilitation outcomes assessment
Changes in walking activity measured by pedometer.
Our primary outcome variable was pre-to postrehabilitation change in pedometer counts per hour of time when the pedometer was worn. Pedometer data were measured during an approximately 1-week period at the beginning of PR and compared with data obtained during a similar time period toward the end of rehabilitation. In general, the pedometer was given to each patient at the first rehabilitation session and returned on a session 1 week later. The total number of pedometer counts for that week was recorded. This process was repeated over the last week of PR. These time periods were chosen to eliminate extra visits to the rehabilitation center, making it more convenient for the patient.
Patients were instructed to wear the pedometer on a belt around the waist, always in the same location, during waking hours. The same instrument was worn at all times by each patient. The pedometer was taken off during the PR sessions. Patients were advised not to view the activity counts on the monitor, although we could not determine whether they complied with this directive. A daily recording of when the device was put on and taken off was completed by the patient. The number of weekend days, weekdays, PR days and non-PR days were recorded by the investigators.
Pedometer data, expressed as counts per hour, were calculated by dividing the total number of counts by the total number of hours worn during each assessment period.
Traditional outcome measures. Pre-and postrehabilitation outcome assessments also included (1) the 6MWT (following a practice effort); the pedometer was also worn during this testing, and the walking distance and pedometer counts were recorded, (2) the 5-point, Medical Research Council (MRC) dyspnea scale, 23 in which higher scores indicate more breathlessness and (3) the total score of the self-administered version of the Chronic Respiratory Disease Questionnaire (CRQ-SR), 24 in which higher scores indicate better health status.
Data analysis
Patient demographics and severity variables are expressed as the means + standard deviations (SD). Comparisons between continuous variables were made using Pearson correlations. Paired t tests were used to compare pre-to post-rehabilitation changes in outcome variables. A general linear model (SAS, Proc GLM) was used to compare outcomes in patients with higher and lower levels of baseline walking activity; means + standard errors are given for this analysis. A p value <.05 was considered significant.
Results

Patient characteristics
Fifty-nine patients were recruited for the study and gave informed consent. Of these, 12 did not qualify for inclusion at baseline testing (pedometermeasured steps not within 20% of counted steps). Two patients did not complete PR or did not provide outcome data. Thus, a total of 45 patients qualified with measured-counted steps, completed PR and had outcome analysis. Their baseline characteristics are shown in Table 1 . On average, the patients had severe COPD, with a mean FEV 1 of 45% + 18% of predicted. Their mean MRC dyspnea rating of approximately 3 indicates a moderate degree of breathlessness where the patients rate themselves as: 'walks slower than people of the same age on the level because of breathlessness or has to stop for breath when walking at own pace on the level.' 23 Nearly half were receiving supplemental oxygen therapy. Patients participated in a total of 17.4 + 4.6 rehabilitation sessions.
Pedometer counts during the initial walking assessment and 6-min walk tests
The pedometer counts and visually counted steps during the baseline testing for the 45 subjects included in the study were 95 and 93, respectively (r ¼ .99, p < .0001). The number of pedometer steps measured during the initial and post-rehabilitation 6MWT was 560 + 123 and 660 + 180 steps, respectively. This difference, which reflected the increase in walk distance (see below), was significant (p < .001). The number of pedometer steps and the corresponding walk distance walked correlated significantly at both the initial and post-rehabilitation assessments: r ¼ .68 and r ¼ .69, respectively (both, p < .0001). There was no significant difference in stride length (distance walked Ä no. of steps) in the two 6MWT: 0.65 + 0.12 vs 0.64 + 0.11 m/step, respectively.
Outcome assessments
Changes in pedometer counts and other outcome variables for the group following PR are shown in Table 2 . The 6-min walk distance, dyspnea and health status improved significantly from baseline to postrehabilitation. The mean increase in the 6-min walk distance (49 m) was close to what has been considered the clinically meaningful change (54 m) 25 in this outcome variable. The mean 10-unit increase in the CRQ-SR is at the threshold for clinically meaningful change for the interviewer-administered version of this health status instrument. 26 The pre-to-postrehabilitation change in the 6MWT was positively correlated with the number of rehabilitation sessions given, r ¼ .46, p ¼ .002. Improvements in the MRC and CRQ did not correlate with the number of rehabilitation sessions. Pedometers were worn for a total of 5.9 + 1.3 and 5.7 + 1.3 days in the initial and end of rehabilitation testing periods, respectively. The pedometers were worn 50 + 9 and 49 + 13 percentage of the day over these two periods, respectively. The devices were worn on 2.2 + 0.7 and 3.8 + 1.4 non-rehabilitation days in the initial assessment; they were worn for 2.2 + 0.7 and 3.5 + 1.2 non-rehabilitation days over these time periods in the end of rehabilitation assessment. These differences were not significant.
Similarly, no differences were noted in the proportion of weekend and weekday use of the pedometers in the two assessments.
The mean number of pedometer steps per hour worn was 207 + 139 in the initial assessment (median 178; range 17 to 787 counts per hour worn). Pedometer steps per hour did not correlate with age, gender, FEV 1 , body mass index (BMI), 6MWT distance, supplemental oxygen requirement, MRC dyspnea or CRQ-SR health status in either assessment period. Pedometer counts increased by 33 + 149 steps per hour worn after, as compared with before PR (p ¼ .14; median 12, range À327 to 562 counts per hour worn). Changes in pedometer counts per hour were not significantly related to the number of days the instrument was worn on weekdays, weekends or days when rehabilitation was given. Changes in pedometer counts per hour did not correlate with baseline values or changes in the 6MWT distance, MRC dyspnea or CRQ-SR health status. There was no significant relationship between the number of rehabilitation sessions and the change in pedometer counts.
Baseline activity levels and changes in pre-to post-rehabilitation outcomes
There was a significant, inverse relationship between baseline pedometer counts and change in pedometer counts per hour: r ¼ À.46, p ¼ .001), suggesting that patients with lower baseline activity levels had greater improvements in walking activity following PR. Using the median number of pedometer counts per hour for the 45 patients (178 counts/hours worn) in the initial assessment, two groups were created: those with higher baseline activity (n ¼ 23) and those with lower activity (n ¼ 22). The mean counts in these groups were 297 and 112, respectively. Patients in these groups were not significantly different with respect to age, gender, FEV 1 percentage-predicted, BMI, 6MWT distance, MRC or CRQ-SR scores. 
Discussion
We tested the utility of pedometers in measuring changes in home-based activity level following PR. While there is considerable evidence to support the effectiveness of comprehensive PR in improving the exercise capacity of patients with COPD, 27 its effect on actual patient activity has been investigated less rigorously. Physical activity is of considerable importance in COPD, since higher levels of activity are associated with a lower rate of decline in lung function, decreased health care utilization and reduced mortality risk. 28, 29 Therefore, measuring activity levels as an outcome in our PR patients is desirable.
Since self-report activity questionnaires have not been particularly accurate in COPD, 4 the direct measurement of activity, especially with a low-cost device is appealing.
Our measurement of steps in the laboratory setting using a commercially available pedometer was reasonably accurate in some -but by no means all -COPD patients referred to our PR programs. Of the 59 patients in our study, 12 (20%) had pedometermeasured steps so far from actual counted steps that an analysis of the data was not possible. Although the pedometer we used had demonstrated accuracy in counting steps in healthy subjects, these patients likely walked at a considerably slower speed, below the sensitivity of the instrument. Our results indicate that, if the pedometer is to be used in PR, it should first be tested for sensitivity and accuracy in the laboratory setting. Even after demonstrating reasonable accuracy in the PR area, it is probable that walking activity in the home setting in some patients might be so slow as to be uncounted by the pedometer. 8 Disappointingly, mean pedometer counts did not change significantly by the end of PR. There was a trend toward increased activity with rehabilitation (þ33 + 149 counts per minute, p ¼ .14). It is possible that a larger sample would have statistical significance to demonstrate this effect. Furthermore, our protocol of activity testing in the first and last week of rehabilitation was designed to minimize additional patient effort by eliminating extra visits to the centers. However, this did reduce the total number of rehabilitation sessions patients underwent between activity testing periods, possibly reducing the demonstrated effectiveness in this area. In contrast, the conventional outcomes of PR, the 6MWT distance, MRC dyspnea and quality of life, all improved significantly following PR. It may be that end-of-PR measures were made too soon to detect behavior change in home-based activity, and that PR therapy may need to be given for a longer period in order to affect home activity behavior change. In a recent study by Pitta and colleagues, 10 walking time in daily life did not improve 3 months following a PR program (p ¼ .21). However, when a 3-month program was followed by an additional 3 months of an exercise program, walking time in daily life did improve significantly (p ¼ .008).
The disparity between improvement in traditionally measured outcome areas and lack of demonstrated improvement in pedometer counts suggests that the pedometer was not sensitive or accurate enough to measure walking activity in our patients, or that our PR intervention has less effect on home- based walking activity, or both. One study used uniaxial accelerometers (which may have been more sensitive to movement than our device) to compare the effectiveness of two approaches to outpatient PR. These investigators did demonstrate significant changes in walking activity following both approaches to PR. 9 Additionally, pedometers may have more utility as feedback devices to individual patients. One study examined the use of pedometers as motivators during PR. Subjects who set specific pedometer count goals walked significantly more steps per day (an increase of 1430 steps/day; 69% from baseline) when compared with subjects not wearing pedometers as part of their rehabilitation prescription. The very modest improvement in the control group (an increase of 455 steps/day; 19% from baseline) is similar to our own results. 16 Clearly, further research is needed in this important area. Our patients wore the pedometer approximately 50% of their day in both evaluation weeks, indicating the pedometer was not worn during all waking hours. It is difficult to determine how this may have influenced our results. Another limitation to pedometermeasured activity is that only lower extremity activity is counted. Upper extremity activity is at least as important for the performance of many activities of daily living, and PR programs usually incorporate upper extremity physical training into their curricula. Changes in upper extremity activity would not be detected with a pedometer. Accelerometers are potentially more useful in this regard, but values for clinically meaningful changes in recorded activity have to be determined for these instruments.
In our sub-analysis, pedometer-measured activity counts did increase significantly following PR among patients with low baseline physical activity, but not among those with initial high activity levels. The basis for the observed differences between change in pedometer counts between low and high activity groups is not clear. Since patients in this lower activity group did not have greater limitation in pulmonary function or exercise capacity, perhaps they were simply more sedentary and thus had greater potential for improvement from exercise training. Alternatively, these patients may walk slowly at baseline, and PR may have taught them to walk faster, thus leading to noted changes in measured pedometer counts. The higher activity group actually had a decrease in pedometer-recorded activity, but this was not significant. The reason that lower extremity activity, assessed by pedometer counts, did not increase in this higher activity group whereas exercise endurance measured by the 6MWT did increase is also not clear. These issues warrant further study.
In summary, the measurement of steps using a commercially available pedometer worn at the waist appears to be reasonably accurate in the laboratory setting in most COPD patients referred to PR. Slower foot speed may be the major limiting factor in those with discrepant results. Nevertheless even after eliminating those without reasonably good concordance of pedometer counts and visually observed steps in the laboratory setting, we could not demonstrate a significant increase in pedometer counts by the end of PR. This lack of effect on home-based walking activity is underscored by the findings of concurrent improvements in the traditional outcome areas of dyspnea, exercise performance measured by the 6MWT and quality of life. We cannot determine from this study whether the pedometer we chose is too insensitive to detect motion in patients with COPD severe enough to be referred to PR or whether home-based activity does not increase much over this relatively short interval. Interestingly, patients with lower pedometermeasured activity at baseline appear to improve more from the PR across several outcome areas. Further studies with more sensitive motion devices and analyses over longer periods of time would be necessary to clarify our findings further.
